🇺🇸 Intravenous Sedation in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 5

Most-reported reactions

1. Bladder Discomfort — 1 report (20%)
2. Complication Of Device Removal — 1 report (20%)
3. Pollakiuria — 1 report (20%)
4. Procedural Pain — 1 report (20%)
5. Urinary Tract Infection — 1 report (20%)

Source database →

Frequently asked questions

Is Intravenous Sedation approved in United States?

Intravenous Sedation does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Intravenous Sedation in United States?

Moscow Regional Research and Clinical Institute (MONIKI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.